WILLIAMS WILLIAM V. enters BRIACELL THERAPEUTICS CORP. with 149.64K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/1/2022ACC: 0001493152-22-020879
DirectorOfficer· President & CEO
Since Aug 2022
149.64K
Baseline shares
100% direct
149.64K
Direct ownership
1 position
249.57K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned149.64K
Total
149.64K direct149.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 149.64K | Direct |
| Total | 149.64K | 149.64K direct |
Derivative Holdings3
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
200K
Shares owned
N/A
Exercise price
4.24
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
22.30K
Shares owned
N/A
Exercise price
8.47
Expiration
—
Exercise window
—
Warrant
DirectUnderlying security
Common Shares
Underlying shares
27.27K
Shares owned
N/A
Exercise price
5.31
Expiration
—
Exercise window
—
Total
Underlying
249.57K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (Right to Buy) Direct | Common Shares | 4.24 | — | — | 200K | N/A |
| Option (Right to Buy) Direct | Common Shares | 8.47 | — | — | 22.30K | N/A |
| Warrant Direct | Common Shares | 5.31 | — | — | 27.27K | N/A |
| Total | 249.57K | 0.00 | ||||